Pharmaceuticals and Multi-layered Government-granted Monopoly
Mylan’s price increase of the EpiPen in late August has caused consternation and a lot of debate about the reasons why Mylan has been able to increase the EpiPen price so dramatically above its production cost. Don’t forget that production cost includes the time and resources that comprise FDA compliance costs, even for generics like …
Pharmaceuticals and Multi-layered Government-granted Monopoly Read More »